Systemic NO synthase inhibition blunts the chronotropic, but not the inotropic response to isoprenaline in man

Nitric Oxide - Biology and Chemistry

Volumn 3, Issue 3, 1999, Pages 209-215

  Schmetterer, Leopold ^a   Dallinger, Susanne ^a   Polak, Kaija ^a   Eichler, Hans Georg ^a   Wolzt, Michael ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Chrontropy; Human; Inotropy; Nitric oxide; adrenoceptor agonists

Indexed keywords

ISOPRENALINE; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE;

ADULT; ARTICLE; CHRONOTROPISM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG RESPONSE; ENZYME ANALYSIS; ENZYME INHIBITION; HEART RATE; HUMAN; INOTROPISM; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASOCONSTRICTION;

EID: 0032776286     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1006/niox.1999.0223     Document Type: Article

References (27)

1. Keaney J. F., Hare J. M., Balligand J. L., Loscalzo J., Smith T. W., Colucci W. S. Inhibition of nitric oxide synthase augments myocardial responses to β-adrenergic stimulation. Am. J. Physiol. 271:1996;H2646-H2652.
2. Sun X., Wie S., Szabo C., Dusting G. J. Depression of the inotropic action of isoprenaline by nitric oxide synthase induction in rat isolated hearts. Eur. J. Pharmacol. 320:1997;29-35.
3. Hare J. M., Loh E., Creager M. A., Colucci W. S. Nitric oxide inhibits the positive inotropic response to β-adrenergic stimulation in humans with left ventricular dysfunction. Circulation. 92:1995;2198-2203.
4. G-nitro-l-arginine methyl ester in conscious rats. Moncada S., Marletta M. A., Hibbs J. B., Higgs E. A. Biology of Nitric Oxide. 1992;23-26 Portland London.
5. Reid I. A., Bui H., Chou L. Role of nitric oxide in the renin and heart rate response to β-adrenergic stimulation. Hypertension. 23:1994;I-49-I-53.
6. Wolzt M., Schmetterer L., Ferber W., Artner E., Mensik C., Eichler H. G., Krejcy K. Effect of nitric oxide-synthase inhibition on renal hemodynamics in man: Reversal by l-arginine. Am. J. Physiol. 272:1997;F178-F182.
7. Schmetterer L., Müller M., Fasching P., Diepolder C., Gallenkamp A., Zanaschka G., Findl O., Strenn K., Mensik C., Tschernko E., Eichler H. G., Wolzt M. Renal and ocular hemodynamic effects of insulin. Diabetes. 46:1997;1868-1874.
8. Schmetterer L., Findl O., Strenn K., Jilma B., Graselli U., Eichler H. G., Wolzt M. Effects of endothelin-1 (ET-1) on ocular hemodynamics. Curr. Eye Res. 16:1997;687-692.
9. Weissler A. M., Harris W. S., Schoenfeld C. D. Systolic time intervals in heart failure in man. Circulation. 37:1968;149-159.
10. De Mey C., Belz G. G., Nixdorf U., Butzer R., Schroeter V., Meyer J., Erbel R. Relative sensitivity of four noninvasive methods in assessing systolic cardiovascular effects of isoprenaline in healthy volunteers. Clin. Pharmacol. Ther. 52:1992;609-619.
11. Wolzt M., Schmetterer L., Rheinberger A., Salomon A., Unfried C., Breiteneder H., Ehringer H., Eichler H. G., Fercher A. F. Comparison of non-invasive methods for the assessment of haemodynamic drug effects in healthy male and female volunteers: Sex differences in cardiovascular responsiveness. Br. J. Clin. Pharmacol. 39:1995;347-359.
12. Jilma B., Kastner J., Mensik C., Hildebrand J., Vondrovec B., Krejcy K., Wagner O., Eichler H. G. Sex differences in nitric oxide production. Life Sci. 58:1996;469-476.
13. Balligand J. L., Kelly R. A., Marsden P. A., Smith T. W., Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc. Natl. Acad. Sci. USA. 90:1993;347-351.
14. Chung M. K., Gulick T. S., Rotondo R. E., Schreiner G. E., Lange L. G. Mechanism of cytokine inhibition of β-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes: Impairment of signal transduction. Circ. Res. 67:1990;753-763.
15. Hare J. M., Givertz M. M., Creager M. A., Colucci W. S. Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure: Potentiation of beta-adrenergic inotropic responsiveness. Circulation. 97:1998;161-166.
16. Stamler J. S., Loh E., Roddy M., Currie K. E., Creager M. A. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation. 89:1994;2035-2040.
17. Haynes W. G., Noon J. P., Walker B. R., Webb D. J. L-NMMA increases blood pressure in man. Lancet. 342:1993;931-932.
18. Schmetterer L., Krejcy K., Kastner J., Wolzt M., Gouya G., Findl O., Lexer F., Breiteneder H., Fercher A. F., Eichler H. G. The effect of systemic nitric oxide-synthase inhibition on ocular fundus pulsations in man. Exp. Eye Res. 64:1997;305-312.
19. Schmetterer L., Findl O., Fasching P., Ferber W., Strenn K., Breiteneder H., Adam H., Eichler H. G., Wolzt M. NO-synthesis and ocular blood flow in patients with insulin-dependent diabetes mellitus. Diabetes. 46:1997;653-658.
20. Schmetterer L., Wolzt M., Graselli U., Findl O., Strenn K., Simak S., Kastner J., Eichler H. G., Singer E. NO-synthase inhibition in the histamine headache model. Cephalalgia. 17:1997;175-182.
21. Paulus W. J., Vantrimpont P. J., Shah A. M. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans: Assessment by bicoronary sodium nitroprusside infusion. Circulation. 89:1994;2070-2078.
22. Klimaschewski L., Kummer W., Mayer B., Couraud J. Y., Preissler U., Philippin B., Heym C. Nitric oxide synthase in cardiac nerve fibers and neurons of rat and guinea pig heart. Circ. Res. 71:1992;1533-1537.
23. Gulick T., Pieper S. J., Murphy M. A., Lange L. G., Schreiner G. F. A new method for assessment of cultured cardiac myocyte contractility detects immune factor-mediated inhibition of β-adrenergic responses. Circulation. 84:1991;313-321.
24. G-Methyl-l-arginine decreases contractility, cGMP and cAMP in isoproterenol-stimulated rat hearts in vitro. Eur. J. Pharmacol. 223:1992;1-7.
25. Rebich S., Devine J. O., Armstead W. M. Role of nitric oxide and cAMP in β-adrenoceptor-induced pial artery vasodilation. Am. J. Physiol. 268:1995;H1071-H1076.
26. 2-Adrenergic dilation of conductance coronary arteries involves flow-dependent NO formation in conscious dogs. Am. J. Physiol. 271:1996;H1926-H1937.
27. Dawes M., Chowienczyk P. J., Ritter J. M. Effect of inhibition of l-arginine/nitric oxide pathway on vasodilation caused by beta-adrenergic agonists in human forearm. Circulation. 95:1997;2293-2297.